Rocket Pharmaceuticals Inc. logo

Rocket Pharmaceuticals Inc. (RCKT)

Market Closed
12 Jun, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
2. 75
+0.09
+3.3835%
$
300.28M Market Cap
- P/E Ratio
- Div Yield
2.44M Volume
-3.06 Eps
$ 2.66
Previous Close
Add Transaction
Day Range
2.66 2.83
Year Range
2.4 5.45
Want to track RCKT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Rocket Pharmaceuticals Inc. (RCKT) Statistics

Valuation metrics

Market Cap 300.28M
Enterprise value 275.44M
Trailing P/E (ttm) -1.47
Forward P/E -
PEG ratio -0.04
Price/Sales (ttm) -
Price/Book (mrq) 1.3
Enterprise Value/Revenue -
Enterprise Value/EBITDA -1.41

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.42M
Average volume (90 days) 3.32M

Price summary

52-Week low 2.4
52-Week high 5.45
Beta -
50-Day moving average 3.37
200-Day moving average 3.7

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:4
Last split Date 5 Jan 2018

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -
Operating margin -

Operational effectiveness

Return on assets -0.73%
Return on equity -0.71%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.87
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 1.29
Total debt (mrq) -
Total Debt/Equity (mrq) 0.1
Current ratio (mrq) 6.12%
Book value per share (mrq) 2.12

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -